Vimarsana
Biggest News Aggregation in the World

Page 4 - Side Effect Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Side Effect Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Side Effect Management Today - Breaking & Trending Today

Patient Education and Monitoring in DLBCL Treatment - Vimarsana News

Patient Education and Monitoring in DLBCL Treatment

Health care experts provide insights into patient education, shared decision-making, and treatment monitoring in DLBCL (diffuse large B cell lymphoma) therapies, reviewing education strategies and response monitoring.

Art Therapy Decreases Anxiety in Children With Cancer - Vimarsana News

Art Therapy Decreases Anxiety in Children With Cancer

Children with cancer tended to feel less anxiety after undergoing four sessions of creative art therapy, recent research showed.

Endometrial Cancer: Managing Toxicities in Lenvatinib and Pembrolizumab - Vimarsana News

Endometrial Cancer: Managing Toxicities in Lenvatinib and Pembrolizumab

Discover strategies for minimizing adverse events and overlapping toxicities in patients undergoing lenvatinib and pembrolizumab therapy for recurrent endometrial cancer.

FDA Grants Orphan Drug Designation for Acute Radiation Syndrome Drug - Vimarsana News

FDA Grants Orphan Drug Designation for Acute Radiation Syndrome Drug

The FDA granted an orphan drug designation for the novel drug, NT-17, to treat people with acute radiation syndrome.

Weekly Fosaprepitant Betters Quality of Life During Chemoradiotherapy - Vimarsana News

Weekly Fosaprepitant Betters Quality of Life During Chemoradiotherapy

Patients with nasopharyngeal carcinoma treated with concurrent chemoradiotherapy reported higher quality of life and were less likely to experience vomiting when receiving fosaprepitant every week as opposed to every three weeks.